You are here

  • Home
  • Archive
  • Volume 11, Issue 3
  • Correction: Nivolumab after selective internal radiation therapy for the treatment of hepatocellular carcinoma: a phase 2, single-arm study

Article Text

Article menu

See original article:

Download PDFPDF

Correction
Correction: Nivolumab after selective internal radiation therapy for the treatment of hepatocellular carcinoma: a phase 2, single-arm study

https://doi.org/10.1136/jitc-2022-005457corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Manuel de la Torre-Aláez M, Matilla A, Varela M, et al. Nivolumab after selective internal radiation therapy for the treatment of hepatocellular carcinoma: a phase 2, single-arm study. Jr ImmunoTher Cancer 2022;10:e005457. doi: 10.1136/jitc-2022-005457.

    This article has been corrected since it was first published. A previous revision of the manuscript was published in error. Supplementary Table S2 is now incorporated in the main article as Table 3, and a new Figure S1 has been included in the supplementary material.